Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools

References

• Global initiative for chronic obstructive lung disease strategy for the diagnosis, management and prevention of COPD 2021. Available from: https://goldcopd.org. Accessed December 7, 2021.
   Google Scholar
• Contreras-Garza BM, Xiong W, Guo X, et al. Update on clinical aspects of COPD. N Engl J Med. 2019;381:2484–2486.
   PubMed Web of Science ®Google Scholar
• Diab N, Gershon AS, Sin DD, et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198:1130–1139. doi:10.1164/rccm.201804-0621CI
   PubMed Web of Science ®Google Scholar
• Yawn BP, Martinez FJ. POINT: can screening for COPD improve outcomes? Yes. Chest. 2020;157(1):7–9. doi:10.1016/j.chest.2019.05.034
   PubMed Web of Science ®Google Scholar
• Mannino DM, Thomashow B. COUNTERPOINT: can screening for COPD improve outcomes? No. Chest. 2020;157(1):9–12. doi:10.1016/j.chest.2019.05.035
   PubMed Web of Science ®Google Scholar
• Çolak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P. Prevalence, characteristics, and prognosis of early chronic obstructive pulmonary disease. The Copenhagen General Population Study. Am J Respir Crit Care Med. 2020;201(6):671–680. doi:10.1164/rccm.201908-1644OC
   PubMed Web of Science ®Google Scholar
• Choi JY, Rhee CK. Diagnosis and treatment of early chronic obstructive lung disease (COPD). J Clin Med. 2020;9(11):3426. doi:10.3390/jcm9113426
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhong NS, Li X, et al. Tiotropium in early-stage chronic obstructive pulmonary disease. N Engl J Med. 2017;377(10):923–935. doi:10.1056/NEJMoa1700228
   PubMed Web of Science ®Google Scholar
• Siu AL, Bibbins-Domingo K, Grossman DC, et al.; US Preventive Services Task Force (USPSTF). Screening for chronic obstructive pulmonary disease: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315(13):1372–1377. doi:10.1001/jama.2016.2638
   PubMed Web of Science ®Google Scholar
• Martinez FJ, O’Connor GT. Screening, case-finding, and outcomes for adults with unrecognized COPD. JAMA. 2016;315(13):1343–1344. doi:10.1001/jama.2016.3274
   PubMed Web of Science ®Google Scholar
• Fujita M, Nagashima K, Takahashi S, Suzuki K, Fujisawa T, Hata A. Handheld flow meter improves COPD detectability regardless of using a conventional questionnaire: a split-sample validation study. Respirology. 2020;25(2):191–197. doi:10.1111/resp.13602
   PubMed Web of Science ®Google Scholar
• Schnieders E, Ünal E, Winkler V, et al. Performance of various COPD case-finding tools: a systematic review and meta-analysis. Eur Respir Rev. 2021;30(160):200350. doi:10.1183/16000617.0350-2020
   PubMed Web of Science ®Google Scholar
• Su KC, Ko HK, Chou KT, et al. An accurate prediction model to identify undiagnosed at-risk patients with COPD: a cross-sectional case-finding study. NPJ Prim Care Respir Med. 2019;29(1):22. doi:10.1038/s41533-019-0135-9
   PubMedGoogle Scholar
• Haroon S, Jordan R, Takwoingi Y, Adab P. Diagnostic accuracy of screening tests for COPD: a systematic review and meta-analysis. BMJ Open. 2015;5(10):e008133. doi:10.1136/bmjopen-2015-008133
   PubMed Web of Science ®Google Scholar
• Haroon SM, Jordan RE, O’Beirne-Elliman J, Adab P. Effectiveness of case finding strategies for COPD in primary care: a systematic review and meta-analysis. NPJ Prim Care Respir Med. 2015;25:15056. doi:10.1038/npjpcrm.2015.56
   PubMed Web of Science ®Google Scholar
• Tsukuya G, Matsumoto K, Fukuyama S, et al.; Hisayama Pulmonary Physiology Study Group. Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study. Allergol Int. 2015;64(1):49–53. doi:10.1016/j.alit.2014.06.002
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Lin CH, Cheng SL, Wang HC, et al. Novel App-based portable spirometer for the early detection of COPD. Diagnostics (Basel). 2021;11(5):785. doi:10.3390/diagnostics11050785
   PubMedGoogle Scholar
• Kim JK, Lee CM, Park JY, et al. Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry. Medicine (Baltimore). 2016;95(50):e5683. doi:10.1097/MD.0000000000005683
   PubMed Web of Science ®Google Scholar
• Represas-Represas C, Fernández-Villar A, Ruano-Raviña A, Priegue-Carrera A, Botana-Rial M; study group of “Validity of COPD-6 in non-specialized healthcare settings”. Screening for chronic obstructive pulmonary disease: validity and reliability of a portable device in non-specialized healthcare settings. PLoS One. 2016;11(1):e0145571. doi:10.1371/journal.pone.0145571
   PubMed Web of Science ®Google Scholar
• Hidalgo Sierra V, Hernández Mezquita MÁ, Palomo Cobos L, et al. Usefulness of the Piko-6 portable device for early COPD detection in primary care. Arch Bronconeumol (Engl Ed). 2018;54(9):460–466. doi:10.1016/j.arbr.2018.07.008
   PubMed Web of Science ®Google Scholar
• Lamprecht B, McBurnie MA, Vollmer WM, et al.; BOLD Collaborative Research Group. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011;139(4):752–763. doi:10.1378/chest.10-1253
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Raczek AE, Seifer FD, et al.; COPD-PS Clinician Working Group. Development and initial validation of a self-scored COPD Population Screener questionnaire (COPD-PS). COPD. 2008;5(2):85–95. doi:10.1080/15412550801940721
   PubMedGoogle Scholar
• Llordés M, Zurdo E, Jaén Á, Vázquez I, Pastrana L, Miravitlles M. Which is the best screening strategy for COPD among smokers in primary care? COPD. 2017;14(1):43–51. doi:10.1080/15412555.2016.1239703
   PubMedGoogle Scholar
• Miravitlles M, Llor C, Calvo E, Diaz S, Díaz-Cuervo H, Gonzalez-Rojas N. Validación de la versión traducida del Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Su utilidad y la del FEV₁/FEV₆ para el diagnóstico de enfermedad pulmonar obstructiva crónica [Validation of the Spanish version of the Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Its usefulness and that of FEV₁/FEV₆ for the diagnosis of COPD]. Med Clin (Barc). 2012;139(12):522–530. doi:10.1016/j.medcli.2011.06.022
   PubMed Web of Science ®Google Scholar
• Spyratos D, Haidich AB, Chloros D, Michalopoulou D, Sichletidis L. Comparison of three screening questionnaires for chronic obstructive pulmonary disease in the primary care. Respiration. 2017;93(2):83–89. doi:10.1159/000453586
   PubMed Web of Science ®Google Scholar
• Sogbetun F, Eschenbacher WL, Welge JA, Panos RJ. A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease. Respir Med. 2016;120:1–9. doi:10.1016/j.rmed.2016.09.010
   PubMed Web of Science ®Google Scholar
• Londhe J, Apte K, Barne M, Salvi S. CAPTURE: a screening tool for chronic obstructive pulmonary disease or obstructive airway disease? Am J Respir Crit Care Med. 2018;197(2):272. doi:10.1164/rccm.201705-1040LE
   PubMed Web of Science ®Google Scholar
• Sui CF, Ming LC, Neoh CF, Ibrahim B. VitalQPlus: a potential screening tool for early diagnosis of COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:1613–1622. doi:10.2147/COPD.S84618
   PubMed Web of Science ®Google Scholar
• Smith LJ. The lower limit of normal versus a fixed ratio to assess airflow limitation: will the debate ever end? Eur Respir J. 2018;51:1800403. doi:10.1183/13993003.00403-2018
   PubMed Web of Science ®Google Scholar
• Enright P, Brusasco V. Counterpoint: should we abandon FEV1/FVC <0.70 to detect airway obstruction? Yes. Chest. 2010;138:1040–1042. doi:10.1378/chest.10-2052
   PubMed Web of Science ®Google Scholar
• Güder G, Brenner S, Angermann CE, et al. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res. 2012;13:13. doi:10.1186/1465-9921-13-13
   PubMed Web of Science ®Google Scholar